iBio, Inc.
IBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001420720
No open-market purchases or sales by iBio, Inc. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $60.8M in total; no superinvestor holds it.
13F holders, Q1 2025
Institutional positions in iBio, Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 34
- +5 vs. Q4 2024
- Shares held
- 2.59M
- −25.2K (−1.0%) vs. Q4 2024
- Total value
- $10.4M
- +$4.00M (+62.5%) vs. Q4 2024
- New holders
- 8
- 10 more added
- Sold out
- 3
- 2 more reduced
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting IBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 55 | $60.8M |
| Q1 2026 | 52 | $36.9M |
| Q4 2025 | 50 | $31.6M |
| Q3 2025 | 32 | $2.96M |
| Q2 2025 | 30 | $2.44M |
| Q1 2025 | 34 | $10.4M |
| Q4 2024 | 30 | $6.40M |
| Q3 2024 | 32 | $5.79M |
| Q2 2024 | 28 | $5.68M |
| Q1 2024 | 28 | $11.5M |
| Q4 2023 | 21 | $344.6K |
| Q3 2023 | 29 | $269.9K |
| Q2 2023 | 29 | $695.7K |
| Q1 2023 | 30 | $3.45M |
| Q4 2022 | 38 | $1.02M |
| Q3 2022 | 46 | $4.97M |
| Q2 2022 | 57 | $7.63M |
| Q1 2022 | 77 | $17.5M |
| Q4 2021 | 83 | $25.0M |
| Q3 2021 | 90 | $47.6M |
| Q2 2021 | 87 | $65.5M |
| Q1 2021 | 94 | $68.5M |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding iBio, Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lynx1 Capital Management LP | 862,279 | $3.47M | 1.24% | 00.0% | Unchanged |
| Ikarian Capital, LLC | 599,913 | $2.41M | 0.79% | 00.0% | Unchanged |
| Opaleye Management Inc. | 375,000 | $1.51M | 0.34% | 00.0% | Unchanged |
| Boothbay Fund Management, LLC | 159,448 | $641.0K | 0.02% | 00.0% | Unchanged |
| Vanguard Group Inc | 143,861 | $578.3K | 0.00% | +70,716+96.7% | Added |
| Geode Capital Management, LLC | 102,609 | $412.5K | 0.00% | +18,812+22.4% | Added |
| Iridian Asset Management LLC | 58,205 | $234.0K | 0.07% | +58,205 | New |
| Cubist Systematic Strategies, LLC | 55,600 | $223.5K | 0.00% | +55,600 | New |
| BlackRock, Inc. | 42,727 | $171.8K | 0.00% | +37,153+666.5% | Added |
| State Street Corp | 33,699 | $135.5K | 0.00% | +33,699 | New |
| Susquehanna International Group, LLP | 32,413 | $130.3K | 0.00% | +32,413 | New |
| Quadrature Capital Ltd | 28,850 | $115.7K | 0.00% | +28,850 | New |
| UBS Group AG | 25,890 | $104.1K | 0.00% | +24,991+2,779.9% | Added |
| Dimensional Fund Advisors LP | 24,150 | $97.1K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 23,044 | $92.6K | 0.00% | +12,879+126.7% | Added |
| Two Sigma Investments, LP | 13,484 | $54.2K | 0.00% | +13,484 | New |
| Morgan Stanley | 3,775 | $15.2K | 0.00% | +3,727+7,764.6% | Added |
| Royal Bank of Canada | 1,000 | $4.00K | 0.00% | +992+12,400.0% | Added |
| SBI Securities Co., Ltd. | 400 | $1.61K | 0.00% | +133+49.8% | Added |
| Advisor Group Holdings, Inc. | 353 | $1.42K | 0.00% | +297+530.4% | Added |
| Group One Trading, L.P. | 156 | $627 | 0.00% | 00.0% | Unchanged |
| SRS Capital Advisors, Inc. | 91 | $366 | 0.00% | −1−1.1% | Reduced |
| Bank of America Corp | 84 | $338 | 0.00% | +10+13.5% | Added |
| Barclays PLC | 82 | $330 | 0.00% | +82 | New |
| Harbour Investments, Inc. | 40 | $161 | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 18 | $72 | 0.00% | −1,603−98.9% | Reduced |
| SOA Wealth Advisors, LLC. | 13 | $52 | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 4 | $16 | 0.00% | 00.0% | Unchanged |
| City Holding Co | 4 | $16 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 2 | $8 | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 2 | $8 | 0.00% | 00.0% | Unchanged |
| Sofos Investments, Inc. | 2 | $8 | 0.00% | +2 | New |
| Wells Fargo & Company | 1 | $4 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 1 | $4 | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 0 | $0 | 0.00% | −415,606−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −42−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −1−100.0% | Sold out |
| Financial Gravity Companies, Inc. | – | – | – | – | Not filed |